Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma — Stella

Home/Hepatocellular Carcinoma (HCC)/

View on ClinicalTrials.gov

Recruiting

Back to Hepatocellular Carcinoma (HCC) trials

Trial locations(1 site)

Serbia

KBC Bežanijska kosa, Belgrade

Key details

Sponsor

University of Belgrade

Enrollment target

~15 participants

Started

August 2024

Primary completion

June 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.